CORONARY CONNECT is an international group of medical experts in the field of coronary heart disease. The Steering Committee and Members address the latest scientific and clinical insights to develop educational programmes, supporting healthcare professionals around the world to offer the best possible care to their patients.
Please submit your clinical topic for the next CORONARY CONNECT newsletter.
Subscribe to the CORONARY CONNECT newsletter to receive updates.
Authored by five CORONARY CONNECT experts, the BluePrint entitled “PCSK9 Inhibition After an Acute Coronary Syndrome: Rationale and Clinical Evidence” is available now for download.
Learn more from Prof. Dr. Kurt Huber about drug therapies for patient management following an ACS event.